Abstract
Cisplatin treatment of tumor-bearing mice resulted a significant decrease of protein in the tissues studied (liver, kidney, and Dalton lymphoma) and also in their mitochondrial fractions. As compared to respective tissues, the protein decrease was noted to be more conspicuous in their mitochondrial fractions. Similarly, mitochondrial glutathione also decreased significantly in the tissues. However, succinate dehydrogenase activity was selectively decreased in the kidney and Dalton lymphoma cells, whereas in liver it remained almost unchanged. An increase in serum urea concentration and kidney mitochondrial lipid peroxidation was also observed after cisplatin treatment. It is suggested that the cisplatin-induced biochemical changes in mitochondria involving mitochondrial protein, glutathione, and succinate dehydrogenase could be the important potent cellular sites contributing to toxicity/cytotoxicity after cisplatin treatment.
Similar content being viewed by others
References
Allen JA, Coombs MM. Covalent binding of polycyclic aromatic compounds to mitochondrial and nuclear DNA. Nature. 1980;287:244-5.
Beatrice MC, Stiers DL, Pfeiffer DR. The role of glutathione in the retention of Ca2+ by liver mitochondria. J Biol Chem. 1984;259:1279-87.
Beltrame M, Sindellari L, Arslan P. Effects of newly synthesised platinum(II) complexes on mitochondrial functions. Chem Biol Interact. 1984;50:247-54.
Brady HR, Kone BC, Stromski ME, Zeidel ML, Giebisch G, Gullans SR. Mitochondrial injury: an early event in cisplatin toxicity to renal proximal tubules. Am J Physiol. 1990;258:F1181-7.
Brown GJ Jr and Cohen PP. Comparative biochemistry of urea synthesis: I. Method for the quantitative assay of urea cycle in liver. J Biol Chem. 1959;234:1769-74.
Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302-10.
Cavalli LR, Liang BC. Mutagenesis, tumorigenicity, and apoptosis: are the mitochondria involved? Mutat Res. 1998;398: 19-26.
De Wit RH, Brabec MG. Protein synthesis by hepatic mitochondria isolated from carbon tetrachloride-exposed rats. Biochim Biophys Acta. 1985;824:256-61.
Esteve JM, Mompo J, DeLaasuncion JG, et al. Oxidative damage to mitochondrial DNA and glutathione oxidation in apoptosis: studies in vivo and in vitro. FASEB J. 1999;13: 1055-64.
Heminger KA, Hartson SD, Rogers J, Matta RL. Cisplatin inhibits protein synthesis in rabbit reticulocyte lysate by causing an arrest in elongation. Arch Biochem Biophys. 1997;344:200-7.
Giri A. Studies on the effect of cisplatin on malignant and normal cells: preliminary investigations on cisplatin combination chemotherapy [PhD thesis]. Shillong: North-Eastern Hill University; 1995.
Go RS, Adjei AA. Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol. 1999;17:409-22.
Just G, Holler E. Enhanced levels of cyclic AMP, adenosine (5')tetraphospho(5')adenosine and nucleoside 5'-triphosphates in mouse leukemia P388/D1 after treatment with cis-diamminedichloroplatinum(II). Biochem Pharmacol. 1991;42:285-91.
Kim YK, Byun HS, Kim YH, Woo LS, Lee SH. Effect of cisplatin on renal function in rabbits: mechanism of reduced glucose reabsorption. Toxicol Appl Pharmacol. 1995;130: 19-26.
King TE. Preparation of succinate dehydrogenase and reconstitution of succinate oxidase. In: Estabrook RW, Pullman ME, eds. Methods in enzymology. Vol. X. New York: Academic Press; 1967:322-31.
Lebwohl D, Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer. 1998;34:1522-34.
LeDoux SP, Wilson GL, Beecham EJ, Stevnsner T, Wassermannn K, Bohr VA. Repair of mitochondrial DNA after various types of DNA damage in Chinese hamster ovary cells. Carcinogenesis. 1992;13:1967-73.
Le-Quoc D, Le-Quoc K. Relationships between the NAD(P) redox state, fatty acid oxidation, and inner membrane permeability in rat liver mitochondria. Arch Biochem Biophys. 1989;273:466-78.
Lewis LD, Hamseh FM, Lietman PS. Ultrastructural changes associated with reduced mitochondrial DNA and impaired mitochondrial function in the presence of 2'3'-dideoxycytidine. Antimicrob Agents Chemother. 1992;36:2061-5.
Li X, Metzger G, Filipski E, et al. Pharmacologic modulation of reduced glutathione circadian rhythms with buthionine sulfoximine: relationship with cisplatin toxicity in mice. Toxicol Appl Pharmacol. 1997;143:281-90.
Lim LO, Neims AH. Mitochondrial DNA damage by bleomycin. Biochem Pharmacol. 1987;36:2769-74.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-75.
Meister A. Glutathione metabolism and its selective modification. J Biol Chem. 1988;263:17205-8.
Murphy MP, Smith RAJ. Drug delivery to mitochondria: the key to mitochondrial medicine. Adv Drug Deliv Rev. 2000; 41:235-50.
Nicotera P, Bellomo G, Orrenius S. Calcium-mediated mechanisms in chemically induced cell death. Annu Rev Pharmacol Toxicol. 1992;32:449-70.
Niranjan BG, Bhat NK, Avadhani NG. Preferential attack of mitochondrial DNA by aflatoxin B1 during hepatocarcinogenesis. Science. 1982;215:73-5.
Olafsdottir K, Pascoe GA, Reed DJ. Mitochondrial glutathione status during Ca2+ ionophore-induced injury to isolated hepatocytes. Arch Biochem Biophys. 1988;263:226-35.
Olivero OA, Semino C, Kassim A, Lopez-Larraza DM, Poirier MC. Preferential binding of cisplatin to mitochondrial DNA of Chinese hamster ovary cells. Mutat Res. 1995;346: 221-30.
Olivero OA, Chang PK, Lopez-Larraza DM, Semino-Mora MC, Poirier MC. Preferential formation and decreased removal of cisplatin-DNA adducts in Chinese hamster ovary cell mitochondrial DNA as compared to nuclear DNA. Mutat Res. 1997;391:79-86.
Pessayre D, Mansouri A, Haouzi D, Fromenty B. Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol. 2000;15:367-73.
Petit PX, LeCouer H, Zorn H, Dauget C, Mignotte B, Gougeon ML. Alteration of mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol. 1995;130:156-67.
Pinto AL, Lippard SJ. Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA. Biochim Biophys Acta. 1985;780:167-80.
Prasad SB, Giri A. Antitumor effect of cisplatin against murine ascites Dalton' lymphoma. Ind J Exp Biol. 1994;32:155-62.
Prasad SB, Giri A. Cisplatin-induced changes in tissue calcium and potassium concentrations in tumour-bearing mice. Med Sci Res. 1999;27:459-62.
Prasad SB, Giri A, Khynriam D. Studies on the chromosomes of murine Dalton' lymphoma cells and the effect of cisplatin on chromosomes of these cells and bone marrow cells in vivo. Cytologia. 1998;63:405-13.
Prasad SB, Giri A, Khynriam D, Kharbangar A, Nicol BM, Lotha C. Cisplatin-mediated enzymatic changes in mice bearing ascites Dalton' lymphoma. Med Sci Res. 1999;27:723-30.
Provoost AP, Molenaar JC. Changes in the glomerular filtration rate after unilateral nephrectomy in rats. Pflugers Arch. 1980;385:161-5.
Rosenberg B. Fundamental studies with cisplatin. Cancer. 1985;55:2303-16.
Salazar I, Tarrago-Litvak L, Gil L, Litvak S. The effect of benzo[a]pyrene on DNA synthesis and DNA polymerase activity in rat liver mitochondria. FEBS Lett. 1982;138:45-9.
Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman' reagent. Anal Biochem. 1968;25:192-205.
Shan X, Jones DP, Hashmi M, Anders MW. Selective depletion of mitochondrial glutathione concentrations by (R,S)-3-hydroxy-4-pentenoate potentiates oxidative cell death. Chem Res Toxicol. 1993;6:75-81.
Smaili SS, Hsu Yi-Te, Youle RJ, Russel T. Mitochondria in Ca2+ signaling and apoptosis. J Bioenerg Biomembr. 2000;32:35-46.
Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991; 51:794-8.
Warburg O. On the origin of cancer cells. Science. 1956;123: 309-14.
White MT, Ayra DV, Tewari KK. Biochemical properties of neoplastic cell mitochondria. J Natl Cancer Inst. 1974;53: 553-9.
Yagi T, Hatefi Y. Thiols in oxidative phosphorylation: inhibition and energy-potentiated uncoupling by monothiol and dithiol modifiers. Biochemistry. 1984;23:2449-55.
Zamble BD, Lippard SJ. Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem Sci. 1995;20:435-9.
Zamzami N, Marchetti P, Castedo M, et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med. 1995; 181:1661-72.
Zglinicki TV, Wiswedel I, Trumper L, Augustin W. Morphological changes of isolated rat liver mitochondria during Fe2+/ascorbate-induced peroxidation and the effect of thioctacid. Mech. Ageing Dev. 1991;57:233-46.
Zhang JG, Lindup WE. Role of calcium in cisplatin-induced cell toxicity in rat renal cortical slices. Toxicol In Vitro. 1996;10:205-9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kharbangar, A., Khynriam, D. & Prasad, S. Effect of cisplatin on mitochondrial protein, glutathione, and succinate dehydrogenase in Dalton lymphoma-bearing mice. Cell Biol Toxicol 16, 363–373 (2000). https://doi.org/10.1023/A:1007648427024
Issue Date:
DOI: https://doi.org/10.1023/A:1007648427024